Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression - Test2 - elhamkhani - TriplyDB

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

http://www.wikidata.org/entity/Q24568374

about

TUC338 promotes cell migration and invasion by targeting TIMP1 in cervical cancer Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.Impact of high glucose on metastasis of colon cancer cells Association between four MMP-9 polymorphisms and breast cancer risk: a meta-analysis.Interplay of N-Cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion.EGFR regulates the development and microarchitecture of intratumoral angiogenic vasculature capable of sustaining cancer cell intravasation.MiR-625-3p promotes cell migration and invasion via inhibition of SCAI in colorectal carcinoma cells.Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR.URGCP promotes non-small cell lung cancer invasiveness by activating the NF-κB-MMP-9 pathway.An epitope-specific novel anti-EMMPRIN polyclonal antibody inhibits tumor progression.CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.Genetic aspects of pituitary carcinoma: A systematic review.Metal complexes and metalloproteases: targeting conformational diseases.Changes in the gene expression of co-cultured human fibroblast cells and osteosarcoma cells: the role of microenvironment TUC.338 promotes invasion and metastasis in colorectal cancer.Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development Factors Promoting Development of Fibrosis in Crohn's Disease.Extracellular Vesicles from Metastatic Rat Prostate Tumors Prime the Normal Prostate Tissue to Facilitate Tumor Growth.Correlation between the COL4A3, MMP-9, and TIMP-1 polymorphisms and risk of keratoconus.Identification of Caspase-6 as a New Regulator of Alternatively Activated Macrophages.Role of TOPK in lipopolysaccharide-induced breast cancer cell migration and invasion.Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.Lentivirus-mediated knockdown of P27RF-Rho inhibits hepatocellular carcinoma cell growth Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma.Long noncoding RNA MIAT promotes non-small cell lung cancer proliferation and metastasis through MMP9 activation.Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy.Identification of novel selective MMP-9 inhibitors as potential anti-metastatic lead using structure-based hierarchical virtual screening and molecular dynamics simulation.Molecular Mechanism of Transcriptional Regulation of Matrix Metalloproteinase-9 in Diabetic Retinopathy.MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.Emerging Therapies in the Management of Advanced-Stage Gastric Cancer Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma The roles of metallothioneins in carcinogenesis Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances

P2860

Q33751104-9589E105-26A6-4B91-BC32-FCB870543F0C Q34494731-BD13472D-D80E-49C0-AC4F-0AA026F51340 Q35078012-FE04C7EB-7148-46FA-BFBB-593BE56EA01B Q35550737-42AA54BC-757F-48E0-883F-A67C45128068 Q36163116-96AE9678-6F3F-4270-ADE3-ED0C60893CAF Q36360133-A95713EB-9B49-4B49-A2D6-6E3988468EB7 Q36413914-18BF3E90-D6E4-4A50-8C9D-C23F205E5095 Q36462450-3F04696D-6204-49FD-9B13-8FF4909657F8 Q36546697-A42CA611-CCC9-4C65-A42A-9762F0C82BAE Q36710986-66576B36-A5B7-4129-95FD-2DC2EC9843B8 Q37046438-E660D508-DAD7-4FD4-A752-4C88C298A8D9 Q37364878-6E3392B9-4E63-4B6E-A091-A9294FBB4726 Q37468122-86B04ECE-3F06-4375-8D43-D8A52063DE67 Q38215608-CE8445F8-5A0C-4A41-86F1-D4ACF789EE8D Q38285949-16FB3CD0-8F85-4745-866B-9495E8EE8E30 Q38727794-FADAA483-E091-4F8E-AFB8-BD6884752729 Q38916371-2C07E94E-C476-43CA-ACC2-29CC5B4C45CD Q39095751-B8D1E514-8C92-4E46-BD25-2E570E60E354 Q39453646-84D476D9-C540-4432-BAEC-ED5D7F8BC19E Q39465138-646A6BDD-440D-412B-A064-2E8126620B7F Q40335943-D597174E-89FF-4832-B929-2E5927C9CDA1 Q41045961-A4E46D5A-81C1-4B33-AE33-66C1605D2AE9 Q41092935-66F01DBA-9B6E-4ED9-8B25-397361BE09DD Q41364250-957D4B0F-2316-45B5-B928-6185E9B06748 Q41824679-3EDA38AB-485E-459B-B189-8C453F9771E8 Q43375964-D79F8389-AB54-4111-921D-5B9689E4A7A7 Q47106319-54FAA10C-5436-486C-831A-A0863A964B52 Q51016986-E5A69069-5EFF-4680-8498-102332F28D64 Q51725776-CB5AFB2B-FB3F-4C88-BB35-02BEFA4CB63B Q53266552-D3DBA170-4CE6-4F02-95F0-BB71DCF60242 Q55233718-8A39B98D-5044-41EE-91D1-EE9F36242FDA Q57111080-D093EA95-A82F-4AFF-A19E-D931CDB2F0FE Q58700294-E1676F99-50A5-46E5-9448-E454A5E10A71 Q58713688-C0F62A5E-D4EE-420F-828D-6F2E57A4AA25 Q59126848-10DA54AC-8A1E-4BE1-AFF8-0707F09589A4

P2860

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

http://www.wikidata.org/entity/Q24568374

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

@ast

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

@en

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

@nl

type

label

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

@ast

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

@en

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

@nl

prefLabel

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

@ast

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

@en

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

@nl

P1433

Q24568374-E75D1631-7090-4CED-9110-2D6993352743

P1476

Q24568374-E87A8566-9361-4A1F-AE59-9D43E90B5C5D

P2093

Q24568374-0D759668-6DCC-4B09-B67B-2516F65969A0

Q24568374-5D63F962-9DDD-4779-B444-38F9A8A73E27

P2860

Q24568374-00AE34F8-E3EA-4869-9593-135C1401794B

Q24568374-0132A864-0772-446F-8F3B-C92DC15C6682

Q24568374-032CF57F-9E3F-46B8-842C-292F30D9B35D

Q24568374-03BC6518-403F-41B5-A3C3-509F593F57DE

Q24568374-046EE5B9-3B46-45E6-8B26-72836395FA70

Q24568374-048B78E8-8F75-4B11-A444-63F3849C2C03

Q24568374-0580634F-FE8A-431E-A5BD-E970EB9F90AD

Q24568374-06AF60F2-B061-4336-8A7D-D64A134D43A3

Q24568374-0778801A-A75A-49E5-9B2A-23EDD40013D3

Q24568374-07B316A2-C9FD-4748-B23E-CB41859B8ACE

P304

Q24568374-7F6FAC06-958B-4D68-981F-BDAF5E8DAA1A

P31

Q24568374-7BE240F3-A436-47D2-9A75-6121408FEAA3

P3181

Q24568374-85AE470E-32EA-40D1-83BC-DBA10EEBC907

P356

Q24568374-7CFDE253-424E-4A9B-A503-48198E923CA7

P407

Q24568374-8306D870-5635-4D89-BE1C-54429A3069C2

P433

Q24568374-F6C8CCDE-5FB1-4148-AA23-D1EB490D271E

P478

Q24568374-AE28C10D-868C-4F4C-9156-3129C39853D4

P50

Q24568374-30FABDFC-D6C8-4B19-9D36-8E2BE6354E45

Q24568374-9B7EAA47-79DF-405E-B049-C29138F132DE

P577

Q24568374-25824FA3-18FB-4853-AD6C-BB83A92DA70A

P5875

Q24568374-ADBF47F9-9DF7-480F-A44B-316BF85F5084

P698

Q24568374-7063386D-6191-40CE-A4D4-A19A00EACE09

P921

Q24568374-C3D686C6-BC7A-491C-B2E3-434FE8F3760D

P932

Q24568374-EB7E941A-C877-4011-8331-9C8FD17E94E6

P3181

P356

P1433

P1476

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

@en

P2093

Andrew Reay Mackay

http://www.w3.org/2001/XMLSchema#string

Antonietta Rosella Farina

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

Hallmarks of Cancer: The Next Generation

Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis

Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins

Meprins process matrix metalloproteinase-9 (MMP-9)/gelatinase B and enhance the activation kinetics by MMP-3

TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma

SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin

P304

240-296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3000023

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/CANCERS6010240

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Andrew Reay Mackay

Antonietta R Farina

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259959556

http://www.w3.org/2001/XMLSchema#string

P698

24473089

http://www.w3.org/2001/XMLSchema#string

P921

P932

3980597

http://www.w3.org/2001/XMLSchema#string